Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Non Operating Investment Income (2016 - 2023)

Historic Non Operating Investment Income for Ironwood Pharmaceuticals (IRWD) over the last 9 years, with Q1 2023 value amounting to $19000.0.

  • Ironwood Pharmaceuticals' Non Operating Investment Income fell 9739.73% to $19000.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $19000.0, marking a year-over-year decrease of 8956.04%. This contributed to the annual value of $19000.0 for FY2023, which is 8956.04% down from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Non Operating Investment Income stood at $19000.0 for Q1 2023, which was down 9739.73% from -$18000.0 recorded in Q4 2022.
  • Over the past 5 years, Ironwood Pharmaceuticals' Non Operating Investment Income peaked at $4.5 million during Q4 2019, and registered a low of -$4.8 million during Q3 2019.
  • In the last 5 years, Ironwood Pharmaceuticals' Non Operating Investment Income had a median value of -$18000.0 in 2022 and averaged -$240176.5.
  • Its Non Operating Investment Income has fluctuated over the past 5 years, first skyrocketed by 19969.6% in 2019, then plummeted by 71095.24% in 2021.
  • Over the past 5 years, Ironwood Pharmaceuticals' Non Operating Investment Income (Quarter) stood at $4.5 million in 2019, then crashed by 90.7% to $420000.0 in 2020, then tumbled by 710.95% to -$2.6 million in 2021, then soared by 99.3% to -$18000.0 in 2022, then surged by 205.56% to $19000.0 in 2023.
  • Its Non Operating Investment Income stands at $19000.0 for Q1 2023, versus -$18000.0 for Q4 2022 and $151000.0 for Q3 2022.